Moderna and OpenAI Collaborate To Advance mRNA Medicine
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P 500, Dow rise on Mideast deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil nears two-month lows on reports of imminent US-Iran peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Morgan Stanley Comments on Moderna (MRNA) Collaboration with OpenAI
April 24, 2024 12:31 PM EDTMorgan Stanley analyst Matthew Harrison reiterated an Equalweight rating and $89.00 price target on Moderna (NASDAQ: MRNA)
The analyst comments "MRNA announced an update regarding the company's ongoing collaboration with OpenAI (privately held) on generative AI tools, noting that the ChatGPT Enterprise is embedded across MRNA's business functions and has achieved more than 80% internal adoption throughout... More
